<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, in the fifth stage, for the top three inhibitors of TMPRSS2 namely, T1 (qingdainone), T2 (edgeworoside C) and T3 (adlumidine), and of cathepsin L namely, C1 (ararobinol), C2 ((+)-oxoturkiyenine) and C3 (3α,17α-cinchophylline), their respective protein-ligand complexes were analyzed using 180 ns MD simulation (
 <xref ref-type="sec" rid="sec3-molecules-25-03822">Section 3</xref>; Figures 8 and 9; 
 <xref ref-type="app" rid="app1-molecules-25-03822">Supplementary Figures S1 and S2</xref>) and their interaction binding energy was computed using MM-PBSA method (
 <xref ref-type="sec" rid="sec3-molecules-25-03822">Section 3</xref>; 
 <xref rid="molecules-25-03822-t003" ref-type="table">Table 3</xref>).
</p>
